Live feed
Filing
SC 13D/A
SC 13D/A0001193125-20-006070·Entasis Therapeutics Holdings Inc.
Schedule 13D ownership disclosure
ENTASIS THERAPEUTICS HLDGS I
Security class unavailable · CUSIP: 293614103
Event date: 2020-01-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-006070
- Form type
- SC 13D/A
- Filer
- Entasis Therapeutics Holdings Inc.
- CIK
- CIK 1724344
- Filed
- Jan 13, 2020
- Reporting period
- Jan 09, 2020
- Description
- Schedule 13D beneficial ownership